港股异动 | 诺诚健华-B(9969.HK)大涨逾13%破顶 市值超330亿港元

格隆汇
16 Feb 2021

格隆汇2月16日丨诺诚健华-B(9969.HK)大幅拉升至13.59%,高见22.65港元再创历史新高价,总市值超330亿港元。


日前诺诚健华-B已经完成配售2.1亿股,当中高瓴资本认购1.92亿股、维梧资本认购1,889.5万股。预计所得款项净额约30.41亿港元,将用于在国内和国际地区扩大和加速正在进行和计划进行的临床试验。

另外,奥布替尼联合治疗临床试验申请获批,诺诚健华董事长兼首席执行官崔霁松表示,目前奥布替尼正在中国及美国进行多中心、多适应症的临床试验。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10